Document is current
Any future updates will be listed below
-
Authors
Mehta, Neel
Gilbert, Rénald https://orcid.org/0000-0002-8265-2111
Chahal, Parminder S.
Moreno, Maria J.
Nassoury, Nasha
Coulombe, Nathalie
Gingras, Richard
Mullick, Alaka
Drouin, Simon
Sasseville, Marc
Latawa, Jyoti
Tiwari, Krishnaraj
Lin, Wendy
Harvey, Emily M. https://orcid.org/0000-0002-8848-5529
Miao, Fudan
Ross, Colin J. D.
Hayden, Michael R. https://orcid.org/0000-0001-5159-1419
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | National Research Council Canada (CGT-101)
Gouvernement du Canada | Canadian Institutes of Health Research (201910MFE-430323-FPP-CAAA-267763)
Michael Smith Foundation for Health Research (RT-2020-0381)
- License Information
-
More Information
Article History
Received: 3 December 2024
Revised: 19 February 2025
Accepted: 4 March 2025
First Online: 26 March 2025
Competing interests
: NM, ReG., PSC, MJM, NC, AM, CJDR, MRH are inventors on a patent application related to this work filed by the University of British Columbia and the National Research Council Canada (PCT/CA2024/050295). MRH currently serves on the public boards of Ionis Pharmaceuticals, Xenon Pharmaceuticals, Aurinia Pharmaceuticals, Abcellera and 89bio. The other authors declare no competing interests.
: All experimental procedures were performed with approval of the Biosafety Committees at the University of British Columbia and the National Research Council of Canada. All procedures involving animals were performed with the approval of the Animal Care Committee at the University of British Columbia and the National Research Council of Canada.
